01 March 2004
Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group
Jerzy R. Kowalczyk, Joanna Nurzyńska, Jerzy Armata, Janina Bogusławska-Jaworska, Roma Rokicka-Milewska, Danuta Sońta-Jakimczyk, Walentyna Balwierz, Alicja Chybicka, Małgorzata Kaczmarek-Kanold, Jacek Wachowiak, Michał Matysiak, Katarzyna PawelecMed Sci Monit 2004; 10(3): CR117-122 :: ID: 11596
Abstract
Background:The development of second malignant neoplasms (SMNs) in patients receiving chemotherapy and radiation therapy for primary cancers is one of the limitations to the quality and length of survival. The present study was undertaken to examine various characteristics of children who developed SMNs following successful therapy for primary leukemia or Hodgkin’s disease (HD).Material/Methods: A total of 3252 children with various forms of leukemia and 849 children with HD treated between, 1970–1997 at 7 pediatric centers of the Polish Pediatric Hematology/Oncology Group and subsequently followed-up entered the study. A second malignancy was diagnosed in 36 of these children.Results: Of the 3252 patients diagnosed as having acute leukemia during this period, 16 developed SMNs (estimated frequency 0.49%). SMNs developed in 20 of the 849 children treated for HD (2.36%). The most frequent SMNs were soft tissue sarcoma and thyroid carcinomas, mainly following Hodgkin’s disease. Other tumors occurred at about the same frequencies in both groups. The interval from the end of initial treatment to diagnosis of an SMN ranged from 2 years 7 months to 17 years 6 months, with a median of 7 yrs 4 mo. for acute lymphoblastic leukemia (ALL) patients and 10 years for children with HD. The estimated accumulated risk of SMN following acute leukemia is 0.95% at 15 years and, for HD, 5.1% at 20 yrs and 7% at 25 yrs.Conclusions: Children who have been successfully treated for one cancer have a higher than expected incidence of additional tumors.
Keywords: Adolescent, Child, Child, Preschool, Follow-Up Studies, Hodgkin Disease - pathology, Hodgkin Disease - therapy, Incidence, Leukemia - pathology, Leukemia - therapy, Leukemia, Lymphocytic, Acute - pathology, Leukemia, Lymphocytic, Acute - therapy, Neoplasms, Second Primary - diagnosis, Neoplasms, Second Primary - epidemiology, Sarcoma - secondary, Soft Tissue Neoplasms - secondary, Thyroid Neoplasms - secondary, Time Factors, Adolescent, Child, Child, Preschool, Follow-Up Studies, Hodgkin Disease - therapy, Incidence, Leukemia - therapy, Neoplasms, Second Primary - epidemiology, Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy, Sarcoma - secondary, Soft Tissue Neoplasms - secondary, Thyroid Neoplasms - secondary, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
07 May 2024 : Clinical Research
Treatment of AVN-Induced Proximal Pole Scaphoid Nonunion Using a Fifth and Fourth Extensor Compartmental Ar...Med Sci Monit In Press; DOI: 10.12659/MSM.944553
16 Mar 2024 : Clinical Research
Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Vario...Med Sci Monit In Press; DOI: 10.12659/MSM.943228
08 May 2024 : Clinical Research
Effect of Individualized PEEP Guided by Driving Pressure on Diaphragm Function in Patients Undergoing Lapar...Med Sci Monit In Press; DOI: 10.12659/MSM.944022
21 Mar 2024 : Clinical Research
Impact of Serum Vitamin D, B6, and B12 and Cognitive Functions on Quality of Life in Peri- and Postmenopaus...Med Sci Monit In Press; DOI: 10.12659/MSM.943249
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952